Diastolische Herzinsuffizienz - Therapie

Schlüsselwörter

CME - Kardiologie

Literatur

• 1 Aurigemma G P, Gaasch W H. Diastolic heart failure.  N Engl J Med. 2004;  351 1097-1105
• 2 Alchanatis M, Tourkohoriti G, Kosmas E N. et al . Evidence for left ventricular dysfunction in patients with obstructive sleep apnoea syndrome.  Eur Respir J. 2002;  20 1239-1245
• 3 Bergstrom A, Andersson B, Edner M, Nylander E, Persson H, Dahlstom U. Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function: Results of the Swedish Doppler-echocardiography study (SWEDIC).  Eur J Heart Fail. 2004;  6 453-461
• 4 Böger R H. Wie wird die chronische Herzinsuffizienz heute tatsächlich behandelt.  Dtsch Med Wochenschr. 2002;  H34 1764
• 5 Böhm M. Werden Herzglykoside zur Therapie der Herzinsuffizienz noch benötigt?.  Dtsch Med Wochenschr. 2002;  41 2133
• 6 Chobanian A V, Bakris G L, Black H R. et al . Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.  Hypertension. 2003;  42 1206
• 7 Colucci W S. Nesiritide for the treatment of decompensated heart failure.  J Card Fail. 2001;  7 92-100
• 8 Devereux R B, Dahlof B, Gerdts E. et al . Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.  Circulation. 2004;  110 1456-1462
• 9 Gandhi S K, Powers J C, Nomeier A M. et al . The pathogenesis of acute pulmonary edema associated with hypertension.  N Engl J Med. 2001;  344 17-22
• 10 Hunt S A, Baker D W, Chin M H. et al . ACC/AHA Guidelines for the evaluation and management of chronic heart failure in the adult: executive summary.  Circulation. 2001;  104 2996-3007
• 11 Kindermann M, Janzen I, Hennen B, Böhm M. Chronische Herzinsuffizienz - Therapie.  Dtsch Med Wochenschr. 2002;  H21 1139
• 12 Remme W J, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure.  Eur Heart J. 2001;  22 1527-1560
• 13 Setaro J F, Zaret B L, Schulman D S. et al . Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance.  Am J Cardiol. 1990;  66 981-986
• 14 The Digitalis Investigation Group . The effect of digoxin on mortality and morbidity in patients with heart failure.  N Eng J Med. 1997;  336 525-533
• 15 Weber K T, Brilla C G. Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosteron-system.  Circulation. 1991;  83 1849-1865
• 16 Yusuf S, Pfeffer M A, Swedberg K. et al . Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial.  Lancet. 2003;  362 777-781
• 17 Zannad F, Allo F, Dousset B. et al . Limitation of the extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators.  Circulation. 2000;  102 2700-2706
• 18 Zile M R, Brutsaert D L. New concepts in diastolic dysfunction and diastolic heart failure: Part II. Causal Mechanisms and Treatment.  Circulation. 2002;  105 1503-1508
• 19 Hader C, Sanner B, Rasche K. Das obstruktive Schlafapnoe-Syndrom - Diagnostik.  Dtsch Med Wochenschr. 2004;  11 566-569
• 20 Sanner B, Hader C, Rasche K. Das obstruktive Schlafapnoe-Syndrom - Therapie.  Dtsch Med Wochenschr. 2004;  11 570-572